IKT
Inhibikase Therapeutics Inc

1,871
Mkt Cap
$179.48M
Volume
490,322.00
52W High
$4.20
52W Low
$1.33
PE Ratio
-2.67
IKT Fundamentals
Price
$1.53
Prev Close
$1.48
Open
$1.52
50D MA
$1.55
Beta
0.94
Avg. Volume
343,096.47
EPS (Annual)
-$1.16
P/B
1.56
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Cantor Fitzgerald Initiates Coverage on Inhibikase Therapeutics (NYSE:IKT)
Cantor Fitzgerald initiated coverage on Inhibikase Therapeutics in a report on Thursday. They issued an "overweight" rating and a $4.00 price target on the stock...
MarketBeat·20h ago
News Placeholder
FY2025 Earnings Estimate for IKT Issued By Lifesci Capital
Inhibikase Therapeutics, Inc. (NYSE:IKT - Free Report) - Lifesci Capital issued their FY2025 EPS estimates for Inhibikase Therapeutics in a report issued on Monday, December 1st. Lifesci Capital...
MarketBeat·8d ago
News Placeholder
Inhibikase Therapeutics (NASDAQ:IKT) Issues Quarterly Earnings Results
Inhibikase Therapeutics (NASDAQ:IKT - Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.13) earnings per share for the quarter...
MarketBeat·26d ago
News Placeholder
Inhibikase Therapeutics (NYSE:IKT) Shares Down 4.4% - Here's What Happened
Inhibikase Therapeutics (NYSE:IKT) Shares Down 4.4% - Here's Why...
MarketBeat·26d ago

Latest IKT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.